Mon, January 4, 2021
Thu, December 31, 2020
Wed, December 30, 2020
Tue, December 29, 2020
Mon, December 28, 2020
Wed, December 23, 2020
Tue, December 22, 2020
Mon, December 21, 2020
Sun, December 20, 2020
Fri, December 18, 2020
Thu, December 17, 2020
Wed, December 16, 2020
Tue, December 15, 2020
Mon, December 14, 2020
Fri, December 11, 2020

Matthew Harrison Maintained (ADCT) at Buy with Increased Target to $56 on, Dec 16th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-56-on-dec-16th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Increased Target from $52 to $56 on, Dec 16th, 2020.

Matthew has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Konstantinos Aprilakis of "Stifel" Initiated at Hold and Held Target at $42 on, Thursday, December 3rd, 2020


This is the rating of the analyst that currently disagrees with Matthew


  • Robert Burns of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $47 on, Thursday, October 29th, 2020

Publication Contributing Sources